Psychosocial factors influencing opioid use and refusal among breast cancer survivors: A multi-methods study

Opioids are often the first-line approach to treat moderate to severe cancer-related pain. However, opioids can cause conflict and distress to cancer survivors when prescribed for pain. The objective of this multi-methods study was to explore the psychosocial factors that affect the use or refusal of opioids among breast cancer survivors. We recruited 20 breast cancer survivors treated with opioids to participate in a free-listing exercise and semi-structured interview. Results revealed that survivors felt unprepared for the intensity of pain following cancer treatments, which contributed to the use of opioids. The adverse side effects often influenced their decision to discontinue them from their pain management strategy. Finally, the addictive properties of the medication affected survivors’ use of the medication. Findings identify and recognize clinicians and researchers can promote safer, more personalized approaches to pain management to inform interventions that integrate behavioral health support and improve patient-provider communication.